Vericel Corporation: Advanced cell therapy; marketing MACI (cartilage repair) and Epicel (skin replacement) in TAMs of $2b+. Record Q4 & 2019 MACI and Epicel revs of $39.4m and $117.9m. 2020 revenue guidance for MACI® and Epicel® raised to $141 to $146m. Expanding MACI salesforce to 76 from 49 reps. NexoBrid BLA filing targeted for mid-2020.
Based in...
US - New England
Clinical Stage
Disease Space
Dermatology, Tools
Biotechnology, Medical Device, Medical Technology
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
Cell Therapy
64 Sidney Street
Cambridge, MA 02139
United States

Top 10 Holders of Vericel Corporation

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RTW Investments LP 8.65 3,850,347 73.62 13F 6/30/20
Brown Capital Management LLC 8.43 3,751,168 71.72 13F 6/30/20
Deerfield Management Company LP 6.87 3,057,161 58.45 13F 6/30/20
State Street Corp. 6.44 2,865,097 54.78 13F 6/30/20
Ivy Investment Management Co. 6.24 2,778,141 53.12 13F 6/30/20
The Vanguard Group, Inc. 5.18 2,307,191 44.11 Funds 8/31/20
Vanguard Group, Inc. (Subfiler) 5.07 2,255,017 43.12 13F 6/30/20
3.62 1,610,154 30.79 13F 6/30/20
BlackRock Fund Advisors 3.45 1,536,229 29.37 13F 6/30/20
BlackRock Institutional Trust Co. NA 3.08 1,371,006 26.21 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.